Lexpos News

/Lexpos News

Legislation restricting the sale and supply of gonadotrophin-releasing hormone analogues further extended

The Government has made The Medicines (Gonadotrophin-Releasing Hormone Analogues) (Emergency Prohibition) (Extension) (No. 2) Order 2024, which has the effect of extending the ban, which was due to expire. The ban has been extended until 31 December 2024. The Secretary of State has expressed the intention to make the ban permanent, but can only do [...]

The post Legislation restricting the sale and supply of gonadotrophin-releasing hormone analogues further extended appeared first on Community Pharmacy England.

By |November 7th, 2024|Lexpos News|Comments Off on Legislation restricting the sale and supply of gonadotrophin-releasing hormone analogues further extended

MHRA Class 4 Medicines Defect Information: Zoledronic Acid Ennogen 4mg/5ml concentrate for solution for infusion (Ennogen Healthcare Limited)

Class 4 Medicines Defect Information: Zoledronic Acid Ennogen 4mg/5ml concentrate for solution for infusion (Ennogen Healthcare Limited) Drug alert number: EL (24)A/53 Date issued: 07 November 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Zoledronic Acid Ennogen 4mg/5ml concentrate for solution for infusion (Ennogen [...]

The post MHRA Class 4 Medicines Defect Information: Zoledronic Acid Ennogen 4mg/5ml concentrate for solution for infusion (Ennogen Healthcare Limited) appeared first on Community Pharmacy England.

By |November 7th, 2024|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Information: Zoledronic Acid Ennogen 4mg/5ml concentrate for solution for infusion (Ennogen Healthcare Limited)

MHRA Drug Safety Update: November 2024

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 18 Issue 4 November 2024) has been published and includes articles on: MedSafetyWeek November 2024: your Yellow Card report helps prevent future harm to others and improves patient safety Letters and medicine recalls sent to healthcare professionals in October 2024 To see the [...]

The post MHRA Drug Safety Update: November 2024 appeared first on Community Pharmacy England.

By |November 6th, 2024|Lexpos News|Comments Off on MHRA Drug Safety Update: November 2024

SPS launches Pharmacy First podcast series

Specialist Pharmacy Service (SPS) has launched a podcast series to discuss some of the issues surrounding the Pharmacy First service and to debunk certain clinical myths around the Clinical pathway strand of the service. In the podcast series, pharmacy colleagues and expert clinical speakers cover the seven clinical conditions included in the Clinical pathway strand [...]

The post SPS launches Pharmacy First podcast series appeared first on Community Pharmacy England.

By |November 6th, 2024|Lexpos News|Comments Off on SPS launches Pharmacy First podcast series

Have you completed the 2024 mandatory workforce survey?

Pharmacy owners are reminded of the requirement to complete the 2024 workforce survey, which is a mandatory requirement for all pharmacy owners. The NHS Business Services Authority sent an email to pharmacy owners containing a link to the survey in October. In some cases, for example, if you work for a multiple pharmacy group, the survey [...]

The post Have you completed the 2024 mandatory workforce survey? appeared first on Community Pharmacy England.

By |November 6th, 2024|Lexpos News|Comments Off on Have you completed the 2024 mandatory workforce survey?